The present disclosure relates generally to methods and apparatus used to provide reduced pressure to cell cultures. More particularly, the present disclosure relates to methods and apparatus used to provide reduced pressure to cell cultures in a substantially airtight enclosure with controlled culture media flow.
Topical negative pressure (TNP) applications have been shown to be beneficial in the treatment of wounds by promoting granulation tissue formation, removing interstitial fluid, drawing wounds closed, and inducing microdeformations at the wound surface. In typical TNP applications, certain parameters may be varied, such as the pressure differential or fluid flow rates. However, it is not always possible to correlate variations in a particular parameter to a response in the wound therapy during in vivo applications, due to the lack of a controlled environment. It is therefore desirable to provide a method and apparatus for providing reduced pressure to cell cultures and measuring the effects of different parameters on TNP applications in a controlled in vitro environment.
It is also desirable to provide a method and apparatus for applying TNP that provides for controlled culture media flow rates and reduces the likelihood that air will be drawn into the cell culture. Such air induction can lead to desiccation of the matrix, thereby preventing meaningful data from being acquired.
In certain embodiments a cell culture system comprises a substantially airtight enclosure configured to culture cells; a first conduit in fluid communication with the substantially airtight enclosure, wherein the first conduit is configured to provide a reduced pressure to the substantially airtight enclosure; and a second conduit in fluid communication with the substantially airtight enclosure, wherein the second conduit is configured to provide a culture media to the substantially airtight enclosure. In other embodiments, a cell matrix is located within the substantially airtight enclosure, and the reduced pressure is applied to a first surface of the cell matrix and the culture media is applied to a second surface of the cell matrix during use. Other embodiments comprise a permeable surface and/or a dressing located within the substantially airtight enclosure. Still other embodiments comprise a permeable surface, a cell matrix and a dressing (or other manifolding material) located within the substantially airtight enclosure, wherein the culture media flows from the second conduit, through the permeable surface, through the cell matrix, through the dressing, and into the first conduit. In certain embodiments, the permeable surface supports the cell matrix and the cell matrix may be located between the permeable surface and the dressing.
Other embodiments comprise a sealing system for a cell culture system comprising a peripheral sealing member configured to engage a plate well and configured to engage a cell culture insert, such that a first seal is formed between the peripheral sealing member and the plate well and a second seal is formed between the peripheral sealing member and the cell culture insert. An insert sealing assembly may also be configured to engage the cell culture insert such that a third seal is formed between the insert sealing assembly and the cell culture insert. In certain embodiments, the peripheral sealing member may be configured to engage an interior wall of the plate well and an exterior wall of the cell culture insert and the insert sealing assembly may be configured to engage an interior wall of the insert. In certain embodiments, a first conduit may extend through the peripheral sealing member and a culture media supply system may be coupled to the first conduit. In other embodiments, second conduit may extend through the peripheral sealing member and a third conduit may extend through the insert sealing assembly. In certain embodiments a low pressure source may be coupled to the third conduit and a fourth conduit may extend through the insert sealing assembly. In certain embodiments the first and second seals may each be created by an interference fit and the peripheral sealing member may be formed by injection molding. In certain embodiments, the insert sealing assembly may comprise an insert sealing member, an insert seal ring, a lateral sealing member, and an insert manifold. In certain embodiments, the insert sealing member and/or the insert manifold may be pressed into the insert. In other embodiments, the insert manifold is threaded into the insert sealing member. In certain embodiments, the insert seal ring may be compressed between the insert sealing member and the insert manifold and the insert sealing member may be formed by injection molding. In certain embodiments, the peripheral sealing member is pressed into the plate well.
Other embodiments comprise a method of culturing cells comprising: providing a substantially airtight enclosure; providing a cell matrix within the substantially airtight enclosure; providing a reduced pressure to the substantially airtight enclosure; and providing a culture media to the substantially airtight enclosure. In certain embodiments, the substantially airtight enclosure comprises a first surface and a second surface, and the reduced pressure is applied to the first surface and the culture media is applied to the second surface. In certain embodiments, the reduced pressure is provided via a first conduit coupled to a low pressure source and the first conduit is in fluid communication with the substantially airtight enclosure. In certain embodiments, the low pressure source is a vacuum pump. In certain embodiments, the culture media may be provided via a second conduit coupled to a culture media supply system and the second conduit is in fluid communication with the substantially airtight enclosure.
Other embodiments comprise a system for culturing cells comprising: a plate well; a cell culture insert; a peripheral sealing member configured to engage a plate well and configured to engage the cell culture insert, such that peripheral sealing member forms a first seal with the plate well and forms a second seal with the cell culture insert; and an insert sealing assembly configured to engage the cell culture insert such that the insert sealing assembly forms a third seal with the cell culture insert. Certain embodiments comprise a first conduit extending through the peripheral sealing member and a low pressure source coupled to the first conduit. In certain embodiments, the second conduit may extend through the insert sealing assembly and a culture media supply system may be coupled to the second conduit. Certain embodiments also comprise a cell matrix in the cell culture insert and a dressing between the cell matrix and the insert sealing assembly.
Referring initially to
In the embodiment of
During use, the embodiment of
In addition, a culture media conduit 70 provides culture media to cell matrix 40 during use of this embodiment. In the embodiment shown, culture media conduit 70 extends through hole 54, notch 25, cavity 56, relief 39, flexible sealing member 59, and into cavity 57. Cell culture media conduit 70 is therefore in fluid communication with components on each side of peripheral sealing member 30. As shown in the schematic in
During use, cell culture system 100 provides topical negative pressure (TNP) to cell matrix 40 and provides culture media 71 to cell matrix 40. In one embodiment, peripheral sealing member 30 (with flexible sealing members 58 and 59) is placed in plate well 10 so that flexible sealing member 59 engages plate well 10. In this embodiment, cell culture container 20 (comprising cell matrix 40) is placed in peripheral sealing member 30 so that flexible sealing member 58 engages cell culture container 20 and tabs 26 align with notches 36. In certain embodiments, dressing 45 is placed on cell matrix 40 and drape 50 is placed across open end 23 of cell culture container 20. As shown in
As shown in
In addition, cell culture system 100 also may provide topical negative pressure (TNP) to cell matrix 40. During operation, low pressure source 65 can create a negative or suction pressure through suction conduit 60 and into dressing 45. Because dressing 45 is a porous material (such as open-cell foam or cotton gauze), cell matrix 40 is also exposed to the suction pressure. Cell matrix 40 is therefore exposed to a pressure differential that encourages the top portion of cell matrix 40 to conform to the bottom surface of dressing 45, which may have an irregular surface comprising indentations and raised portions. Such a process of deforming the cell matrix 40 by contact with a non-planar surface (known as microdeformation) can stimulate cellular activity in the cell matrix through the induction of mechanical strain (known as mechanotransduction). In addition, the pressure differential across cell matrix 40 also promotes the migration of culture media 71 into cell matrix 40, further promoting growth of cells in cell matrix 40. Furthermore, the pressure differential across drape 50 can cause drape 50 to deform to cell culture container 20 and dressing 45.
As shown in
In the embodiment disclosed in
In certain embodiments, cell culture system 100 may be part of a larger assembly. As shown in
In addition, each suction conduit 60 is coupled together via flexible tubing 87 to a common connector 88. Common connector 88 may then be coupled to a low pressure source such as vacuum pump 65 (shown in
In certain embodiments, cell matrix 40 is porous enough to allow media culture 71 to flow through it, and strong enough to withstand TNP without cell proliferation. One example of such a matrix comprises porcine whole blood in sodium citrate spun down to separate out the cells from the plasma. In this embodiment, plasma may be assayed for fibrinogen and 2 mL of 9.8 mg/mL is placed in each cell culture container 20. The cells may then be seeded into plasma at approximately 20,000 cells per cell culture container 20, and 0.5 mL of Thrombin (1083 units per mL in culture media 71) may be added drop-wise onto the plasma/cell mixture. After cell matrix 140 has set up, culture media 71 can be added to the bottom of cell culture container 20 and to the top of cell matrix 140. In this embodiment, cells may be allowed to proliferate for approximately two weeks prior to further experimentation. In certain embodiments, immediately prior to experimentation, 1 mL of an agar (such as Tryptic Soy agar at a concentration of 40 g/L) may be added to the top of the matrix. The thin agar layer can be used to stabilize cell matrix 140 during TNP while still being porous enough to allow fluid flow.
Another embodiment of a cell culture system 200 is shown in
Referring now to the detailed cross-section of
As shown in
A top view of assembled cell culture system 200 is shown in
Referring now to
Referring now to
Referring now to
Referring now to
Referring now to
In other embodiments, the cell culture container may be any device suitable for culturing cells and may be a device other than a cell culture insert. Referring now to
During use, this embodiment operates in a manner equivalent to the previously-described embodiments, and suction conduit 460 applies negative pressure to a first surface 441 (shown here as an upper surface) of cell matrix 440. In addition, culture media conduit 470 provides culture media 470 to a second surface 442 (shown here as a lower surface) of cell matrix 440. As shown, peripheral walls 419, floor 420, and lid 450 provide a substantially airtight enclosure 421 that effectively seals cell culture matrix 440 (with the exception of suction conduit 460 and culture media conduit 470). In this embodiment, suction conduit 460 extends through lid 450 and (when coupled to a low pressure source) can be used to control the amount of negative pressure that is applied to cell culture matrix 440. Similarly, culture media conduit 470 extends through peripheral wall 419 and can be used to control the amount of culture media 471 provided to cell culture matrix 440.
In the embodiment shown, cell culture container 410 does not require a separate peripheral sealing member between it and a larger assembly (such as a well plate) because cell culture media conduit 470 extends through peripheral wall 419 of cell culture container 410. Cell culture system 400 may operate with a single cell culture container 410 or multiple cell culture containers 410. In the embodiment shown, permeable support 422 may comprise any one of a number of different configurations. For example, permeable support 422 may comprise a mesh material, a perforated barrier, or membrane. In this embodiment, lid 450 may be a flexible drape similar to those in previously described embodiments, or lid 450 may be a more rigid member that engages peripheral walls 419 in a sealing manner. The disclosed embodiment is provided for purpose of example only, and modifications and variations of the disclosed embodiment are within the scope of the invention.
Throughout this disclosure, reference to a “seal between” two components does not require that the two components make contact with each other. Additional components may be located between two or more components that have a seal between them. Reference in this disclosure to “low”, “reduced”, “negative” or “suction” pressure refers to any pressure less than atmospheric pressure.
In certain embodiments, peripheral sealing member 230, insert sealing member 254 and insert manifold 260 (and other components) may be manufactured by injection molding. Other embodiments may comprise cast parts, non-standard o-ring sizes, or alternate materials. In certain embodiments, insert 20 and plate well 10 (as well as other components) may be standard components that are readily available (or “off-the-shelf”) items. The utilization of such standard components can minimize the amount of sterilization that must be performed, because such components may be treated as disposable or consumable components.
In certain embodiments, the medium flow may be automatically controlled using a closed-loop feedback system that incorporates pressure, flow, or other parameter sensors, and the medium flow may be ramped, reversed, cycled or recycled. In certain embodiments, plate wells may be coupled in parallel or in series, and a gas injection or temperature control device may be added. In certain embodiments, optical radiation (UV to IR) may be added by incorporating LED's or other microelectronics to the system, as well as optical sensors or imaging devices. Electromagnetic, electrostatic, and magnetic fields may be induced by incorporating these field generators in or around the plate wells. Certain embodiments may comprise mechanical strain-inducing devices, such as MEMS, or microfluidics, and the system may be used for the study of nematodes, parasites, microbes, or small insects.
In certain embodiments, tissue samples having irregular shapes could be sealed to the insert by wax casting or similar means. In certain embodiments, portions of membrane 22 may be occluded and the apical surface of the culture may have a partially occluded cover in order to control the direction and velocity of the flow through the culture. For example, occluding all but the outer margin of membrane 22 and occluding all but a central hole in an apical cover could induce radial flow.
In certain embodiments, cell matrix 140 may comprise bovine fibrinogen and thrombin instead of plasma. Embodiments may also comprise various other biocompatible polymers and or extracellular matrix components such as Puramatrix™, chitosan, starch or collagen, provided cell matrix 140 is able to withstand TNP without collapsing. In other embodiments, cell matrix 140 may comprise resorbable materials, implantable mixes, tissue samples such as split thickness skin grafts or thin slices of tissue such as dentin or bone.
While the present invention has been shown and described in detail above, it will be clear to the person skilled in the art that changes and modifications may be made without departing from the scope of the invention. As such, that which is set forth in the foregoing description and accompanying drawings is offered by way of illustration only and not as a limitation. The actual scope of the invention is intended to be defined by the following claims, along with the full range of equivalents to which such claims are entitled.
In addition, one of ordinary skill in the art will appreciate upon reading and understanding this disclosure that other variations for the invention described herein can be included within the scope of the present invention. For example, in certain embodiments, peripheral sealing members 30 and 230 may be one component. In other embodiments, peripheral sealing members 30 and 230 may be comprised of multiple components.
In the foregoing Detailed Description of Disclosed Embodiments, various features are grouped together in several embodiments for the purpose of streamlining the disclosure. This method of disclosure is not to be interpreted as reflecting an intention that the embodiments of the invention require more features than are expressly recited in each claim. Rather, as the following claims reflect, inventive subject matter lies in less than all features of a single disclosed embodiment. Thus, the following claims are hereby incorporated into the Detailed Description of Disclosed Embodiments, with each claim standing on its own as a separate embodiment.
This application claims priority to U.S. Provisional Patent Application No. 60/759,723, filed Jan. 18, 2006, the entire text of which disclosure is specifically incorporated by reference herein without disclaimer.
Number | Name | Date | Kind |
---|---|---|---|
1355846 | Rannells | Oct 1920 | A |
2547758 | Keeling | Apr 1951 | A |
2632443 | Lesher | Mar 1953 | A |
2682873 | Evans et al. | Jul 1954 | A |
2910763 | Lauterbach | Nov 1959 | A |
2969057 | Simmons | Jan 1961 | A |
3066672 | Crosby, Jr. et al. | Dec 1962 | A |
3367332 | Groves | Feb 1968 | A |
3520300 | Flower, Jr. | Jul 1970 | A |
3568675 | Harvey | Mar 1971 | A |
3648692 | Wheeler | Mar 1972 | A |
3682180 | McFarlane | Aug 1972 | A |
3826254 | Mellor | Jul 1974 | A |
4080970 | Miller | Mar 1978 | A |
4096853 | Weigand | Jun 1978 | A |
4139004 | Gonzalez, Jr. | Feb 1979 | A |
4165748 | Johnson | Aug 1979 | A |
4184510 | Murry et al. | Jan 1980 | A |
4233969 | Lock et al. | Nov 1980 | A |
4245630 | Lloyd et al. | Jan 1981 | A |
4256109 | Nichols | Mar 1981 | A |
4261363 | Russo | Apr 1981 | A |
4275721 | Olson | Jun 1981 | A |
4284079 | Adair | Aug 1981 | A |
4297995 | Golub | Nov 1981 | A |
4333468 | Geist | Jun 1982 | A |
4373519 | Errede et al. | Feb 1983 | A |
4382441 | Svedman | May 1983 | A |
4392853 | Muto | Jul 1983 | A |
4392858 | George et al. | Jul 1983 | A |
4419097 | Rowland | Dec 1983 | A |
4465485 | Kashmer et al. | Aug 1984 | A |
4475909 | Eisenberg | Oct 1984 | A |
4480638 | Schmid | Nov 1984 | A |
4525166 | Leclerc | Jun 1985 | A |
4525374 | Vaillancourt | Jun 1985 | A |
4540412 | Van Overloop | Sep 1985 | A |
4543100 | Brodsky | Sep 1985 | A |
4548202 | Duncan | Oct 1985 | A |
4551139 | Plaas et al. | Nov 1985 | A |
4569348 | Hasslinger | Feb 1986 | A |
4605399 | Weston et al. | Aug 1986 | A |
4608041 | Nielsen | Aug 1986 | A |
4640688 | Hauser | Feb 1987 | A |
4655754 | Richmond et al. | Apr 1987 | A |
4664662 | Webster | May 1987 | A |
4710165 | McNeil et al. | Dec 1987 | A |
4733659 | Edenbaum et al. | Mar 1988 | A |
4743232 | Kruger | May 1988 | A |
4758220 | Sundblom et al. | Jul 1988 | A |
4787888 | Fox | Nov 1988 | A |
4826494 | Richmond et al. | May 1989 | A |
4838883 | Matsuura | Jun 1989 | A |
4840187 | Brazier | Jun 1989 | A |
4863449 | Therriault et al. | Sep 1989 | A |
4872450 | Austad | Oct 1989 | A |
4878901 | Sachse | Nov 1989 | A |
4897081 | Poirier et al. | Jan 1990 | A |
4906233 | Moriuchi et al. | Mar 1990 | A |
4906240 | Reed et al. | Mar 1990 | A |
4919654 | Kalt et al. | Apr 1990 | A |
4941882 | Ward et al. | Jul 1990 | A |
4953565 | Tachibana et al. | Sep 1990 | A |
4969880 | Zamierowski | Nov 1990 | A |
4985019 | Michelson | Jan 1991 | A |
5037397 | Kalt et al. | Aug 1991 | A |
5086170 | Luheshi et al. | Feb 1992 | A |
5092858 | Benson et al. | Mar 1992 | A |
5100396 | Zamierowski | Mar 1992 | A |
5134994 | Say | Aug 1992 | A |
5149331 | Ferdman et al. | Sep 1992 | A |
5167613 | Karami et al. | Dec 1992 | A |
5176663 | Svedman et al. | Jan 1993 | A |
5215522 | Page et al. | Jun 1993 | A |
5232453 | Plass et al. | Aug 1993 | A |
5261893 | Zamierowski | Nov 1993 | A |
5272083 | Butz et al. | Dec 1993 | A |
5278100 | Doan et al. | Jan 1994 | A |
5279550 | Habib et al. | Jan 1994 | A |
5298015 | Komatsuzaki et al. | Mar 1994 | A |
5342376 | Ruff | Aug 1994 | A |
5344415 | DeBusk et al. | Sep 1994 | A |
5358494 | Svedman | Oct 1994 | A |
5437622 | Carion | Aug 1995 | A |
5437651 | Todd et al. | Aug 1995 | A |
5474065 | Meathrel et al. | Dec 1995 | A |
5497771 | Rosenheimer | Mar 1996 | A |
5527293 | Zamierowski | Jun 1996 | A |
5549584 | Gross | Aug 1996 | A |
5556375 | Ewall | Sep 1996 | A |
5607388 | Ewall | Mar 1997 | A |
5636643 | Argenta et al. | Jun 1997 | A |
5645081 | Argenta et al. | Jul 1997 | A |
5665596 | Mussi | Sep 1997 | A |
6071267 | Zamierowski | Jun 2000 | A |
6135116 | Vogel et al. | Oct 2000 | A |
6207448 | Rozga et al. | Mar 2001 | B1 |
6241747 | Ruff | Jun 2001 | B1 |
6287316 | Agarwal et al. | Sep 2001 | B1 |
6345623 | Heaton et al. | Feb 2002 | B1 |
6488643 | Tumey et al. | Dec 2002 | B1 |
6493568 | Bell et al. | Dec 2002 | B1 |
6553998 | Heaton et al. | Apr 2003 | B2 |
6814079 | Heaton et al. | Nov 2004 | B2 |
20020077661 | Saadat | Jun 2002 | A1 |
20020115951 | Norstrem et al. | Aug 2002 | A1 |
20020120185 | Johnson | Aug 2002 | A1 |
20020143286 | Tumey | Oct 2002 | A1 |
20060172412 | Perrier et al. | Aug 2006 | A1 |
Number | Date | Country |
---|---|---|
550575 | Aug 1982 | AU |
745271 | Apr 1999 | AU |
755496 | Feb 2002 | AU |
2005436 | Jun 1990 | CA |
26 40 413 | Mar 1978 | DE |
43 06 478 | Sep 1994 | DE |
295 04 378 | Oct 1995 | DE |
0100148 | Feb 1984 | EP |
0117632 | Sep 1984 | EP |
0161865 | Nov 1985 | EP |
0358302 | Mar 1990 | EP |
1018967 | Aug 2004 | EP |
692578 | Jun 1953 | GB |
2 195 255 | Apr 1988 | GB |
2 197 789 | Jun 1988 | GB |
2 220 357 | Jan 1990 | GB |
2 235 877 | Mar 1991 | GB |
2 333 965 | Aug 1999 | GB |
2 329 127 | Aug 2000 | GB |
4129536 | Apr 1992 | JP |
71559 | Apr 2002 | SG |
WO 8002182 | Oct 1980 | WO |
WO 8704626 | Aug 1987 | WO |
WO 9010424 | Sep 1990 | WO |
WO 9309727 | May 1993 | WO |
WO 9420041 | Sep 1994 | WO |
WO 9605873 | Feb 1996 | WO |
WO 9718007 | May 1997 | WO |
WO 9913793 | Mar 1999 | WO |
WO 02072423 | Sep 2002 | WO |
WO 02072423 | Sep 2002 | WO |
Number | Date | Country | |
---|---|---|---|
20070166817 A1 | Jul 2007 | US |
Number | Date | Country | |
---|---|---|---|
60759723 | Jan 2006 | US |